Most cited papers from Targepeutics (United States)
What are the most cited papers from Targepeutics (United States)?
The most cited paper from Targepeutics (United States) is "IL-13Rα2 Status Predicts GB-13 (IL13.E13K-PE4E) Efficacy in High-Grade Glioma" (Julian S. Rechberger, Kendra A. Porath, Liang Zhang et al., 2022), with 13 citations. Next come "Targeting IL-13Rα2 for effective treatment of malignant peripheral nerve sheath tumors in mouse models" (7) and "Radiotherapy plus neoadjuvant and concomitant IL-13Rα2-directed immunotoxin therapy for diffuse intrinsic pontine glioma" (2).
Showing 4 of 4 papers. Every paper is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | IL-13Rα2 Status Predicts GB-13 (IL13.E13K-PE4E) Efficacy in High-Grade Glioma Julian S. Rechberger, Kendra A. Porath, Liang Zhang et al. · Pharmaceutics | 24 Apr 2022 | 13 |
| 2 | Targeting IL-13Rα2 for effective treatment of malignant peripheral nerve sheath tumors in mouse models Oliver Mrowczynski, Russell A. Payne, Alexandre Jose Bourcier et al. · Journal of neurosurgery | 27 Feb 2019 | 7 |
| 3 | Radiotherapy plus neoadjuvant and concomitant IL-13Rα2-directed immunotoxin therapy for diffuse intrinsic pontine glioma Julian S. Rechberger, Wouter J. F. Vanbilloen, Leo F. Nonnenbroich et al. · Communications Biology | 15 Jan 2026 | 2 |
| 4 | Synthesis, Radiolabeling and Preclinical Evaluation of [89Zr]Zr-DFO-GB13 in Diffuse Midline Glioma Mouse Model Viktoria E. Krol, Aditya Bansal, Liang Zhang et al. · Nuclear Medicine and Biology | Nov 2025 | 0 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.